Cargando…
Concurrent chemoradiotherapy plus anlotinib vs. concurrent chemoradiotherapy alone in locally advanced nasopharyngeal carcinoma: An interim analysis of a multicenter randomized controlled trial
Despite the use of intensity-modulated radiation therapy (IMRT) and concurrent chemotherapy (CCRT), the treatment of locoregionally advanced nasopharyngeal carcinoma (LA-NPC) is not satisfactory. EGFR and VEGFR are highly expressed in 60–80% of patients with LA-NPC and this is associated with a poor...
Autores principales: | Chen, Kequan, Xu, Guoding, Liang, Yong, Liang, Ping, Gao, Weiwei, Li, Zhou, Liang, Weichao, Tao, Zheng, Chen, Jiaxin, Hu, Xiaohua, Xu, Yaocan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435931/ https://www.ncbi.nlm.nih.gov/pubmed/37600344 http://dx.doi.org/10.3892/ol.2023.13978 |
Ejemplares similares
-
Comparison of Induction Chemotherapy Plus Concurrent
Chemoradiotherapy and Concurrent Chemoradiotherapy Alone in Locally Advanced
Nasopharyngeal Carcinoma
por: Xu, Guoqiang, et al.
Publicado: (2021) -
Induction Chemotherapy Plus Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma in Children and Adolescents: A Matched Cohort Analysis
por: Li, Yang, et al.
Publicado: (2018) -
Identification of surrogate endpoints in patients with locoregionally advanced nasopharyngeal carcinoma receiving neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone
por: Chen, Yu-Pei, et al.
Publicado: (2015) -
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients with cervical nodal necrosis
por: Lan, Mei, et al.
Publicado: (2017) -
Efficacy of concurrent chemoradiotherapy plus Endostar compared with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study
por: Yin, Yuanxiu, et al.
Publicado: (2022)